Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


ConMed gains surgical imaging tech with $22.5m Viking buy

This article was originally published in Clinica

Executive Summary

Surgical devices specialist ConMed has agreed to acquire Viking Systems, giving it a 3D imaging system for use during minimally-invasive surgery. The agreed price of $0.27 per share, or $22.5m in total, represents a 42% premium over Viking's closing share price of $0.19 on 13 August, the day before the deal was announced. The transaction is expected to close in the fourth quarter. Viking's lead product, the Viking 3D-HD Vision System, is a three-dimensional vision system which employs a flat screen monitor and passive glasses, and is used by surgeons in various laparoscopic procedures, including urologic, gynaecologic, bariatric, cardiac, neurologic and general surgery. The Westborough, Massachusetts company claims the device is the only stand-alone 3D laparoscopic vision system that is both US FDA-cleared and CE-marked for sale in Europe. ConMed (Utica, New York) manufactures products for eight segments: arthroscopy, electrosurgery, endoscopy, endoscopic technologies, endosurgery, integrated systems, patient care and powered surgical instruments.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts